• 2023
  Nekkab N, Obadia T, Monteiro WM, Lacerda MVG, White M, Mueller I, Accelerating towards P. vivax elimination with a novel serological test-and-treat strategy: a modelling case study in Brazil., Lancet Reg Health Am 2023 Jun; 22(): 100511.
• 2023
  Woudenberg T, Pinaud L, Garcia L, Tondeur L, Pelleau S, De Thoisy A, Donnadieu F, Backovic M, Attia M, Hozé N, Duru C, Koffi AD, Castelain S, Ungeheuer MN, Fernandes Pellerin S, Planas D, Bruel T, Cauchemez S, Schwartz O, Fontanet A, White M, Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021., Euro Surveill 2023 Jun; 28(25): .
• 2023
  Kervevan J, Staropoli I, Slama D, Jeger-Madiot R, Donnadieu F, Planas D, Pietri MP, Loghmari-Bouchneb W, Alaba Tanah M, Robinot R, Boufassa F, White M, Salmon-Ceron D, Chakrabarti LA, Divergent adaptive immune responses define two types of long COVID., Front Immunol 2023 ; 14(): 1221961.
• 2022
  Bruel T, Pinaud L, Tondeur L, Planas D, Staropoli I, Porrot F, Guivel-Benhassine F, Attia M, Pelleau S, Woudenberg T, Duru C, Koffi AD, Castelain S, Fernandes-Pellerin S, Jolly N, De Facci LP, Roux E, Ungeheuer MN, Van Der Werf S, White M, Schwartz O, Fontanet A, , Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study., EClinicalMedicine 2022 Sep; 51(): 101576.
• 2022
  Obadia T, Gutierrez-Bugallo G, Duong V, Nuñez AI, Fernandes RS, Kamgang B, Hery L, Gomard Y, Abbo SR, Jiolle D, Glavinic U, Dupont-Rouzeyrol M, Atyame CM, Pocquet N, Boyer S, Dauga C, Vazeille M, Yébakima A, White MT, Koenraadt CJM, Mavingui P, Vega-Rua A, Veronesi E, Pijlman GP, Paupy C, Busquets N, Lourenço-de-Oliveira R, De Lamballerie X, Failloux AB, , Zika vector competence data reveals risks of outbreaks: the contribution of the European ZIKAlliance project., Nat Commun 2022 Aug; 13(1): 4490.
• 2022
  Garcia L, Woudenberg T, Rosado J, Dyer AH, Donnadieu F, Planas D, Bruel T, Schwartz O, Prazuck T, Velay A, Fafi-Kremer S, Batten I, Reddy C, Connolly E, McElheron M, Kennelly SP, Bourke NM, White MT, Pelleau S, , Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination., Viruses 2022 07; 14(7): .
• 2022
  Obadia T, Nekkab N, Robinson LJ, Drakeley C, Mueller I, White MT, , Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment., BMC Med 2022 03; 20(1): 98.
• 2021
  Huber JH, Koepfli C, España G, Nekkab N, White MT, Alex Perkins T, , How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites., Malar J 2021 Dec; 20(1): 479.
• 2021
  Champagne C, Gerhards M, Lana J, García Espinosa B, Bradley C, González O, Cohen JM, Le Menach A, White MT, Pothin E, , Using observed incidence to calibrate the transmission level of a mathematical model for Plasmodium vivax dynamics including case management and importation., Math Biosci 2021 Dec; 343(): 108750.
• 2021
  Pelleau S, Woudenberg T, Rosado J, Donnadieu F, Garcia L, Obadia T, Gardais S, Elgharbawy Y, Velay A, Gonzalez M, Nizou JY, Khelil N, Zannis K, Cockram C, Merkling SH, Meola A, Kerneis S, Terrier B, de Seze J, Planas D, Schwartz O, Dejardin F, Petres S, von Platen C, Pellerin SF, Arowas L, de Facci LP, Duffy D, Cheallaigh CN, Dunne J, Conlon N, Townsend L, Duong V, Auerswald H, Pinaud L, Tondeur L, Backovic M, Hoen B, Fontanet A, Mueller I, Fafi-Kremer S, Bruel T, White M, , Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection., J Infect Dis 2021 11; 224(9): 1489-1499.
• 2021
  Rodero MP, Pelleau S, Welfringer-Morin A, , Duffy D, Melki I, Bader-Meunier B, , , Onset and Relapse of Juvenile Dermatomyositis Following Asymptomatic SARS-CoV-2 Infection., J Clin Immunol 2021 Aug; (): .
• 2021
  Gul D, Rodríguez-Rodríguez D, Nate E, Auwan A, Salib M, Lorry L, Keven JB, Katusele M, Rosado J, Hofmann N, Ome-Kaius M, Koepfli C, Felger I, Kazura JW, Hetzel MW, Mueller I, Karl S, Clements ACA, Fowkes FJI, Laman M, Robinson LJ, , Investigating differences in village-level heterogeneity of malaria infection and household risk factors in Papua New Guinea., Sci Rep 2021 Aug; 11(1): 16540.
• 2021
  Woudenberg T, Pelleau S, Anna F, Attia M, Donnadieu F, Gravet A, Lohmann C, Seraphin H, Guiheneuf R, Delamare C, Stefic K, Marlet J, Brochot E, Castelain S, Augereau O, Sibilia J, Dubos F, Meddour D, Guen CG, Coste-Burel M, Imbert-Marcille BM, Chauvire-Drouard A, Schweitzer C, Gatin A, Lomazzi S, Joulié A, Haas H, Cantais A, Bertholon F, Chinazzo-Vigouroux MF, Abdallah MS, Arowas L, Charneau P, Hoen B, Demeret C, Werf SV, Fontanet A, White M, , Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France., EBioMedicine 2021 Aug; 70(): 103495.
• 2021
  Minassian AM, Silk SE, Barrett JR, Nielsen CM, Miura K, Diouf A, Loos C, Fallon JK, Michell AR, White MT, Edwards NJ, Poulton ID, Mitton CH, Payne RO, Marks M, Maxwell-Scott H, Querol-Rubiera A, Bisnauthsing K, Batra R, Ogrina T, Brendish NJ, Themistocleous Y, Rawlinson TA, Ellis KJ, Quinkert D, Baker M, Lopez Ramon R, Ramos Lopez F, Barfod L, Folegatti PM, Silman D, Datoo M, Taylor IJ, Jin J, Pulido D, Douglas AD, de Jongh WA, Smith R, Berrie E, Noe AR, Diggs CL, Soisson LA, Ashfield R, Faust SN, Goodman AL, Lawrie AM, Nugent FL, Alter G, Long CA, Draper SJ, , Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination., Med (N Y) 2021 Jun; 2(6): 701-719.e19.
• 2021
  Longley RJ, White MT, Brewster J, Liu ZSJ, Bourke C, Takashima E, Harbers M, Tham WH, Healer J, Chitnis CE, Monteiro W, Lacerda M, Sattabongkot J, Tsuboi T, Mueller I, , IgG Antibody Responses Are Preferential Compared With IgM for Use as Serological Markers for Detecting Recent Exposure to Plasmodium vivax Infection., Open Forum Infect Dis 2021 Jun; 8(6): ofab228.
• 2021
  Dufloo J, Grzelak L, Staropoli I, Madec Y, Tondeur L, Anna F, Pelleau S, Wiedemann A, Planchais C, Buchrieser J, Robinot R, Ungeheuer MN, Mouquet H, Charneau P, White M, Lévy Y, Hoen B, Fontanet A, Schwartz O, Bruel T, , Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies., Cell Rep Med 2021 05; 2(5): 100275.
• 2021
  Nekkab N, Lana R, Lacerda M, Obadia T, Siqueira A, Monteiro W, Villela D, Mueller I, White M, , Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study., PLoS Med 2021 04; 18(4): e1003535.
• 2021
  Zaloumis SG, Whyte JM, Tarning J, Krishna S, McCaw JM, Cao P, White MT, Dini S, Fowkes FJI, Maude RJ, Kremsner P, Dondorp A, Price RN, White NJ, Simpson JA, , Development and validation of an in silico decision-tool to guide optimisation of intravenous artesunate dosing regimens for severe falciparum malaria patients., Antimicrob Agents Chemother 2021 Mar; (): .
• 2021
  Villasis E, Garro K, Rosas-Aguirre A, Rodriguez P, Rosado J, Gave A, Guzman-Guzman M, Manrique P, White M, Speybroeck N, Vinetz JM, Torres K, Gamboa D, , PvMSP8 as a Novel Plasmodium vivax Malaria Sero-Marker for the Peruvian Amazon., Pathogens 2021 Mar; 10(3): .
• 2021
  Niang M, Sandfort M, Mbodj AF, Diouf B, Talla C, Faye J, Sane R, Thiam LG, Thiam A, Badiane A, Vigan-Womas I, Diagne N, Diene Sarr F, Mueller I, Sokhna C, White M, Toure-Balde A, , Fine-scale spatio-temporal mapping of asymptomatic and clinical P. falciparum infections: epidemiological evidence for targeted malaria elimination interventions., Clin Infect Dis 2021 Mar; (): .
• 2021
  Kunkel A, White M, Piola P, , Novel anti-malarial drug strategies to prevent artemisinin partner drug resistance: A model-based analysis., PLoS Comput Biol 2021 Mar; 17(3): e1008850.
• 2021
  Lana R, Nekkab N, Siqueira AM, Peterka C, Marchesini P, Lacerda M, Mueller I, White M, Villela D, , The top 1%: quantifying the unequal distribution of malaria in Brazil., Malar J 2021 Feb; 20(1): 87.
• 2021
  Rosado J, Pelleau S, Cockram C, Merkling SH, Nekkab N, Demeret C, Meola A, Kerneis S, Terrier B, Fafi-Kremer S, de Seze J, Bruel T, Dejardin F, Petres S, Longley R, Fontanet A, Backovic M, Mueller I, White MT, , Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study., Lancet Microbe 2021 Feb; 2(2): e60-e69.
• 2021
  Rosado J, White MT, Longley RJ, Lacerda M, Monteiro W, Brewster J, Sattabongkot J, Guzman-Guzman M, Llanos-Cuentas A, Vinetz JM, Gamboa D, Mueller I, , Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts., PLoS Negl Trop Dis 2021 02; 15(2): e0009165.
• 2021
  Chotirat S, Nekkab N, Kumpitak C, Hietanen J, White MT, Kiattibutr K, Sa-Angchai P, Brewster J, Schoffer K, Takashima E, Tsuboi T, Harbers M, Chitnis CE, Healer J, Tham WH, Nguitragool W, Mueller I, Sattabongkot J, Longley RJ, , Application of 23 Novel Serological Markers for Identifying Recent Exposure to Plasmodium vivax Parasites in an Endemic Population of Western Thailand., Front Microbiol 2021 ; 12(): 643501.
• 2020
  Ondigo BN, Hamre KES, Frosch AEP, Ayodo G, White MT, John CC, , Antibody Profiles to P. falciparum Antigens Over Time Characterize Acute and Long-Term Malaria Exposure in an Area of Low and Unstable Transmission., Am J Trop Med Hyg 2020 12; 103(6): 2189-2197.
• 2020
  Sandfort M, Vantaux A, Kim S, Obadia T, Pepey A, Gardais S, Khim N, Lek D, White M, Robinson LJ, Witkowski B, Mueller I, , Forest malaria in Cambodia: the occupational and spatial clustering of Plasmodium vivax and Plasmodium falciparum infection risk in a cross-sectional survey in Mondulkiri province, Cambodia., Malar J 2020 Nov; 19(1): 413.
• 2020
  Martin DL, Saboyà-Díaz MI, Abashawl A, Alemayeh W, Gwyn S, Hooper PJ, Keenan J, Kalua K, Szwarcwald CL, Nash S, Oldenburg C, West SK, White M, Solomon AW, , The use of serology for trachoma surveillance: Current status and priorities for future investigation., PLoS Negl Trop Dis 2020 09; 14(9): e0008316.
• 2017
  Rosado J, Morales S, López G, Clark D, Verdonck K, Gotuzzo E, Van Camp G, Talledo M, , The FAS-670 AA genotype is associated with high proviral load in peruvian HAM/TSP patients., J Med Virol 2017 04; 89(4): 726-731.
• 2012
  Pelleau S, Diop S, Dia Badiane M, Vitte J, Beguin P, Nato F, Diop BM, Bongrand P, Parzy D, Jambou R, , Enhanced basophil reactivities during severe malaria and their relationship with the Plasmodium falciparum histamine-releasing factor translationally controlled tumor protein., Infect Immun 2012 Aug; 80(8): 2963-70.
• 2012
  Razakandrainibe R, Pelleau S, Grau GE, Jambou R, , Antigen presentation by endothelial cells: what role in the pathophysiology of malaria?, Trends Parasitol 2012 Apr; 28(4): 151-60.
• 2011
  Pelleau S, Bertaux L, Briolant S, Ferdig MT, Sinou V, Pradines B, Parzy D, Jambou R, , Differential association of Plasmodium falciparum Na+/H+ exchanger polymorphism and quinine responses in field- and culture-adapted isolates of Plasmodium falciparum., Antimicrob Agents Chemother 2011 Dec; 55(12): 5834-41.
• 2011
  Sinou V, Quang le H, Pelleau S, Huong VN, Huong NT, Tai le M, Bertaux L, Desbordes M, Latour C, Long LQ, Thanh NX, Parzy D, , Polymorphism of Plasmodium falciparum Na(+)/H(+) exchanger is indicative of a low in vitro quinine susceptibility in isolates from Viet Nam., Malar J 2011 Jun; 10(): 164.
• 2011
  Briolant S, Pelleau S, Bogreau H, Hovette P, Zettor A, Castello J, Baret E, Amalvict R, Rogier C, Pradines B, , In vitro susceptibility to quinine and microsatellite variations of the Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) gene: the absence of association in clinical isolates from the Republic of Congo., Malar J 2011 Feb; 10(): 37.
• 2009
  Henry M, Briolant S, Zettor A, Pelleau S, Baragatti M, Baret E, Mosnier J, Amalvict R, Fusai T, Rogier C, Pradines B, , Plasmodium falciparum Na+/H+ exchanger 1 transporter is involved in reduced susceptibility to quinine., Antimicrob Agents Chemother 2009 May; 53(5): 1926-30.
• 2006
  Migot-Nabias F, Pelleau S, Watier L, Guitard J, Toly C, De Araujo C, Ngom MI, Chevillard C, Gaye O, Garcia A, , Red blood cell polymorphisms in relation to Plasmodium falciparum asymptomatic parasite densities and morbidity in Senegal., Microbes Infect 2006 Aug; 8(9-10): 2352-8.
• 2006
  Sarr JB, Pelleau S, Toly C, Guitard J, Konaté L, Deloron P, Garcia A, Migot-Nabias F, , Impact of red blood cell polymorphisms on the antibody response to Plasmodium falciparum in Senegal., Microbes Infect 2006 Apr; 8(5): 1260-8.
• 2006
  De Araujo C, Migot-Nabias F, Guitard J, Pelleau S, Vulliamy T, Ducrocq R, , The role of the G6PD AEth376G/968C allele in glucose-6-phosphate dehydrogenase deficiency in the seerer population of Senegal., Haematologica 2006 Feb; 91(2): 262-3.